Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco
The presentation will be accessible via a Webcast through a link posted onthe Investor Relations, Events Calendar section of the Nektar website:http://www.nektar.com. This Webcast will be available for replay untilFebruary 15, 2009.
Nektar Therapeutics is a biopharmaceutical company developing noveltherapeutics based on its advanced polymer conjugate technology platforms.Nektar's technology and drug development expertise have enabled nine approvedproducts for partners, which include leading biopharmaceutical companies.Nektar is also developing a robust pipeline of its own high-value therapeuticsthat addresses unmet medical needs by leveraging and expanding its technologyplatforms to improve and enable molecules. For more information on NektarTherapeutics, please visit http://www.nektar.com.Nektar Contacts: Jennifer Ruddock Nektar Therapeutics 650-631-4954 email@example.com Susan Noonan The SAN Group 212-966-3650 firstname.lastname@example.org
SOURCE Nektar Therapeutics
You May Also Like